Fengling Li

10.3k total citations
129 papers, 4.8k citations indexed

About

Fengling Li is a scholar working on Molecular Biology, Immunology and Plant Science. According to data from OpenAlex, Fengling Li has authored 129 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Molecular Biology, 11 papers in Immunology and 11 papers in Plant Science. Recurrent topics in Fengling Li's work include Epigenetics and DNA Methylation (36 papers), Cancer-related gene regulation (33 papers) and RNA modifications and cancer (17 papers). Fengling Li is often cited by papers focused on Epigenetics and DNA Methylation (36 papers), Cancer-related gene regulation (33 papers) and RNA modifications and cancer (17 papers). Fengling Li collaborates with scholars based in Canada, United States and China. Fengling Li's co-authors include Masoud Vedadi, C.H. Arrowsmith, Peter J. Brown, Ljerka Kunst, Jian Jin, Scott E. Plevy, Huanquan Zheng, Matthieu Schapira, Dalia Baršytė-Lovejoy and Reinhard Jetter and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Fengling Li

124 papers receiving 4.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fengling Li Canada 39 3.4k 749 429 319 285 129 4.8k
Christopher Horst Lillig Germany 42 5.0k 1.5× 376 0.5× 413 1.0× 267 0.8× 1.1k 3.7× 87 6.9k
Mauro Degli Esposti Italy 44 4.9k 1.5× 312 0.4× 467 1.1× 277 0.9× 491 1.7× 133 6.6k
Ming Yu China 29 1.8k 0.5× 694 0.9× 310 0.7× 362 1.1× 121 0.4× 119 4.1k
Yun‐Ru Chen Taiwan 40 2.7k 0.8× 518 0.7× 544 1.3× 316 1.0× 100 0.4× 158 5.2k
Yutaka Kawarabayasi Japan 35 3.8k 1.1× 322 0.4× 298 0.7× 322 1.0× 358 1.3× 101 5.1k
Ilka Wittig Germany 52 7.5k 2.2× 326 0.4× 621 1.4× 671 2.1× 434 1.5× 190 9.6k
Alfred Hausladen United States 30 2.5k 0.7× 629 0.8× 528 1.2× 156 0.5× 770 2.7× 49 4.8k
Marina Gritsenko United States 40 3.1k 0.9× 388 0.5× 421 1.0× 313 1.0× 63 0.2× 98 5.1k
Gianluca Damonte Italy 37 2.0k 0.6× 367 0.5× 685 1.6× 177 0.6× 90 0.3× 160 5.1k

Countries citing papers authored by Fengling Li

Since Specialization
Citations

This map shows the geographic impact of Fengling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengling Li more than expected).

Fields of papers citing papers by Fengling Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengling Li. The network helps show where Fengling Li may publish in the future.

Co-authorship network of co-authors of Fengling Li

This figure shows the co-authorship network connecting the top 25 collaborators of Fengling Li. A scholar is included among the top collaborators of Fengling Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengling Li. Fengling Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wang, Mengqi, Ji Qi, Fengling Li, et al.. (2025). Paper-based fluorescence chip with umbellately anchored dimeric G-quadruplex coupled DNA tetrahedron-structured probe for sensing DNA methyltransferase. Sensors and Actuators B Chemical. 446. 138643–138643. 1 indexed citations
3.
Perveen, Sumera, Aliakbar Khalili Yazdi, Taraneh Hajian, Fengling Li, & Masoud Vedadi. (2024). Kinetic characterization of human mRNA guanine-N7 methyltransferase. Scientific Reports. 14(1). 4509–4509. 2 indexed citations
5.
Eguida, Merveille, Guillaume Bret, Fengling Li, et al.. (2024). Subpocket Similarity-Based Hit Identification for Challenging Targets: Application to the WDR Domain of LRRK2. Journal of Chemical Information and Modeling. 64(13). 5344–5355. 4 indexed citations
6.
Xiong, Yan, Holger Greschik, C. Johansson, et al.. (2024). Discovery of a Potent, Selective, and Cell-Active SPIN1 Inhibitor. Journal of Medicinal Chemistry. 67(7). 5837–5853. 2 indexed citations
7.
Zou, Bin, Shuang Zhang, Xiaoqing Xu, et al.. (2023). Glycyrrhetinic acid attenuates endoplasmic reticulum stress-induced hepatocyte apoptosis via CHOP/DR5/Caspase 8 pathway in cholestasis. European Journal of Pharmacology. 961. 176193–176193. 6 indexed citations
8.
Hanley, Ronan P., Yan Nie, Fengling Li, et al.. (2023). Discovery of a Potent and Selective Targeted NSD2 Degrader for the Reduction of H3K36me2. Journal of the American Chemical Society. 145(14). 8176–8188. 32 indexed citations
9.
Kimani, Serah, Sumera Perveen, Hong Zeng, et al.. (2023). The co-crystal structure of Cbl-b and a small-molecule inhibitor reveals the mechanism of Cbl-b inhibition. Communications Biology. 6(1). 1272–1272. 12 indexed citations
10.
Vu, Victoria, Fengling Li, Abdellah Allali‐Hassani, et al.. (2023). Development of LM-41 and AF-2112, two flufenamic acid-derived TEAD inhibitors obtained through the replacement of the trifluoromethyl group by aryl rings. Bioorganic & Medicinal Chemistry Letters. 95. 129488–129488. 8 indexed citations
11.
Vu, Victoria, Fengling Li, Abdellah Allali‐Hassani, et al.. (2023). Development of HC-258, a Covalent Acrylamide TEAD Inhibitor That Reduces Gene Expression and Cell Migration. ACS Medicinal Chemistry Letters. 14(12). 1746–1753. 9 indexed citations
12.
Luciani, Genna M., Victoria Vu, Raquel A. C. Machado, et al.. (2023). Epigenetic vulnerabilities of leukemia harboring inactivating EZH2 mutations. Experimental Hematology. 130. 104135–104135. 3 indexed citations
13.
Li, Alice, Dimitrios Panagopoulos, Fengling Li, et al.. (2021). Rational Design and Synthesis of Selective PRMT4 Inhibitors: A New Chemotype for Development of Cancer Therapeutics**. ChemMedChem. 16(7). 1116–1125. 11 indexed citations
14.
Mazzone, Roberta, Irene del Molino del Barrio, Annalidia Donato, et al.. (2020). Inhibition of the SUV4-20 H1 histone methyltransferase increases frataxin expression in Friedreich's ataxia patient cells. Journal of Biological Chemistry. 295(52). 17973–17985. 9 indexed citations
15.
Wolstenhulme, Stephen, Anthony Tumber, Stephanie B. Hatch, et al.. (2017). Discovery of a Highly Selective Cell‐Active Inhibitor of the Histone Lysine Demethylases KDM2/7. Angewandte Chemie. 129(49). 15761–15765. 1 indexed citations
16.
Wolstenhulme, Stephen, Anthony Tumber, Stephanie B. Hatch, et al.. (2017). Discovery of a Highly Selective Cell‐Active Inhibitor of the Histone Lysine Demethylases KDM2/7. Angewandte Chemie International Edition. 56(49). 15555–15559. 33 indexed citations
17.
Xiong, Yan, Fengling Li, Nicolas Babault, et al.. (2017). Structure-activity relationship studies of G9a-like protein (GLP) inhibitors. Bioorganic & Medicinal Chemistry. 25(16). 4414–4423. 26 indexed citations
18.
Davé, Shaival H., Jeremy S. Tilstra, Katsuyoshi Matsuoka, et al.. (2007). Amelioration of Chronic Murine Colitis by Peptide-Mediated Transduction of the IκB Kinase Inhibitor NEMO Binding Domain Peptide. The Journal of Immunology. 179(11). 7852–7859. 73 indexed citations
19.
Li, Fengling. (2006). Plant Lectin and its Application in the Genetic Engineering of Plant Resistance to Insects. Anhui nongye kexue. 1 indexed citations
20.
Li, Fengling, et al.. (2000). Effects of gibberellin and light on seed germination and seedling growth of Arabidopsis. 26(2). 101–104. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026